-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Recursion Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2019 to 2023.
- Recursion Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$97.5M, a 27.1% decline year-over-year.
- Recursion Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$375M, a 44.2% decline year-over-year.
- Recursion Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$328M, a 37% decline from 2022.
- Recursion Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$239M, a 28.4% decline from 2021.
- Recursion Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$186M, a 114% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)